Accurate diagnosis and assessment of diabetic polyneuropathy (DPN) is essential for initiating preventative measures and treatment.
Why this matters
DPN is a length-dependent symmetrical sensorimotor polyneuropathy and is one of the most common and problematic complications of diabetes.
Reports of its prevalence range from 13–55%; variation in prevalence is thought to be attributed to differences in study populations and defining criteria.
Accurate and early identification of DPN can help to minimize long-term effects and initiate preventative measures and treatment.